Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.061 AUD 0.00(0%)
Last update at 2026-11-12T04:59:00Z
VOLUME
1693
Market Cap
9.57M

Momentum Score

…

Nuchev Limited engages in the nutrition and wellness business across consumer, practitioner, distribution, and digital channels in Australia, China, Vietnam, and New Zealand. It offers goat-milk food and beverages; natural liquid vitamins; skincare products; and functional nutrition for weight wellness and vitality under the Oli6, Brauer, Skin Physics, and Rapid Loss brands. The company also provides clinically validated formulations, practitioner education, and professional support; bioavailable, well-tolerated formulations for energy, muscle, and nervous system support; alkaline mineral formulations; homeopathic solutions; liquid formulations; and herbal remedies under the Bio-Practica, Magnesium Diasporal, Basica, Heel, Brauer Professional, and Medicine Tree brands. In addition, it offers children's snacking products, goat functional food products, and full cream goat milk powder formats. The company sells its products through pharmacy, grocery, retail, and e-commerce channels; and digital platforms, as well as healthcare practitioners, clinics, health food stores, and other specialist channels. Nuchev Limited was incorporated in 2013 and is headquartered in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.06
Low
0.06
High
52 Week Price Range
0.06
Low
0.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Nuchev Ltd is an Australian company focused on developing and supplying cannabinoid-based medicines and wellness products for clinical and consumer use. Long-term growth may be supported by rising medical cannabis acceptance, expansion of product portfolios and clinical evidence, and opportunities in domestic and export markets, which could make the company attractive to investors seeking regulated cannabis exposure.

Key risks include regulatory shifts affecting market access and approvals, competitive pressure from larger pharmaceutical and consumer firms, clinical or product development setbacks, and capital or execution constraints.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.06
Dividend Yield
-
Revenue TTM
25.68M
Revenue Per Share
0.17
Gross Profit TTM
11.21M
Debt / Equity
0.71
ROE
-86.11%
Net Debt
2.07M
ROCE
-51.35%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -7.39M -3.82M -7.32M -8.81M -11.11M
Net income -7.39M -3.82M -7.32M -8.81M -11.81M
Selling general administrative 15.97M 3.35M 7.53M 7.04M 6.10M
Selling and marketing expenses - 4.98M 3.41M 3.06M 5.51M
Gross profit 3.19M 10.86M 3.63M 1.66M 2.78M
Reconciled depreciation 0.62M 0.73M 0.11M 0.19M 0.20M
Ebit -5.39M -4.35M -7.29M -8.19M -10.40M
Ebitda -4.76M -3.73M -7.18M -8.00M -10.20M
Depreciation and amortization 0.62M 0.63M 0.11M 0.19M 0.20M
Operating income -5.39M -3.57M -6.46M -8.19M -10.40M
Other operating expenses 31.07M 26.51M 17.73M 17.20M 20.40M
Interest expense 0.28M 0.04M 0.03M 0.07M 0.01M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.11M 0.17M 0.09M 0.01M 0.01M
Net interest income -0.17M 0.14M 0.06M -0.07M -0.02M
Income tax expense - - 0.00M 0.29M 0.70M
Total revenue 25.68M 22.94M 11.34M 8.79M 9.72M
Total operating expenses 8.58M 14.43M 10.02M 10.07M 13.46M
Cost of revenue 22.49M 12.08M 7.72M 7.14M 6.95M
Total other income expense net -2.00M -0.25M -0.86M -0.33M -0.71M
Net income from continuing ops -7.39M -3.82M -7.32M -8.81M -11.11M
Net income applicable to common shares - -3.82M -7.32M -8.81M -11.11M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 19.60M 17.39M 20.09M 15.32M 17.75M
Intangible assets 1.99M 2.34M - 0.00M 0.51M
Other current assets 1.18M 0.32M 0.49M 0.01M 0.01M
Total liab 13.67M 6.16M 5.34M 2.51M 1.92M
Total stockholder equity 5.93M 11.23M 14.75M 12.82M 15.83M
Deferred long term liab - - - - 0.26M
Other current liab 5.60M 4.16M 3.25M 0.01M 1.01M
Common stock 113.23M 111.04M 111.06M 101.86M 96.04M
Capital stock 113.23M - - 101.86M 96.04M
Retained earnings -109.46M -102.07M -98.25M -90.93M -82.12M
Other liab - - - 0.08M 0.08M
Good will - 1.87M 4.22M - -
Other assets - - 0.00M 0.08M 0.71M
Cash 2.13M 3.61M 7.61M 7.48M 5.11M
Cash and equivalents - - - 0.33M 0.33M
Total current liabilities 9.11M 5.39M 4.94M 2.19M 1.84M
Current deferred revenue 0.02M - - 1.43M -
Net debt 2.07M -3.21M -7.29M -7.19M -4.96M
Short term debt 0.21M 0.12M 0.09M 0.05M 0.15M
Short long term debt total 4.19M 0.39M 0.32M 0.28M 0.15M
Other stockholder equity - - - 1.89M 1.92M
Property plant equipment - - - 0.35M 0.13M
Total current assets 16.60M 12.40M 15.22M 14.60M 16.66M
Long term investments 0.15M - - 0.32M 0.38M
Net tangible assets - - - 12.82M 15.58M
Short term investments - - - 0.02M 0.01M
Net receivables 5.90M 2.93M 2.13M 0.67M 1.66M
Long term debt 3.50M - - - -
Inventory 7.39M 5.54M 4.98M 5.31M 9.35M
Accounts payable 3.28M 1.11M 1.60M 0.70M 0.67M
Accumulated other comprehensive income 2.16M 2.26M 1.94M 1.89M 1.92M
Non currrent assets other 0.08M 0.08M 0.08M 0.06M 0.07M
Non current assets total 3.01M 4.99M 4.87M 0.73M 1.09M
Capital lease obligations 0.69M - - 0.28M 0.15M
Long term debt total - - - 0.24M 0.00M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -0.14M -2.19M -0.13M -0.91M
Change to liabilities - - - 0.33M 0.29M
Total cashflows from investing activities -0.08M -0.14M -2.19M -0.13M -0.91M
Net borrowings 3.50M - - -0.15M -0.12M
Total cash from financing activities 5.27M -0.12M 6.06M 5.78M -0.12M
Change to operating activities - - - 0.00M -0.01M
Net income -7.39M -3.82M -7.32M -8.81M -11.81M
Change in cash -1.48M -4.00M 0.13M 2.37M -9.40M
Begin period cash flow 3.61M 7.61M 7.48M 5.11M 14.51M
End period cash flow 2.13M 3.61M 7.61M 7.48M 5.11M
Total cash from operating activities -6.64M -3.74M -3.73M -3.26M -11.61M
Issuance of capital stock 1.93M - 6.51M 6.53M -
Depreciation 0.62M 0.73M 0.11M 0.14M 0.20M
Other cashflows from investing activities - -0.03M 0.00M 0.00M -1.08M
Change to inventory -2.01M -0.40M 2.32M 4.05M 2.00M
Change to account receivables -3.56M -0.77M -0.26M 0.33M -0.57M
Sale purchase of stock - -0.02M -0.29M -0.60M 0.00M
Other cashflows from financing activities -0.16M -0.02M -0.09M -0.15M -0.12M
Change to netincome - - - 0.64M 0.91M
Capital expenditures 0.02M 0.18M 0.01M 0.13M 0.01M
Change in working capital -2.14M -1.26M 3.27M 0.05M 0.13M
Stock based compensation - 0.32M 0.06M - -
Other non cash items 2.26M 0.30M 0.15M - 11.61M
Free cash flow -6.66M -3.93M -3.74M -3.38M -11.62M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NUC
Nuchev Ltd
-
-%
0.06 - - 0.37 1.85 0.51 -0.60
A2M
The a2 Milk Company Ltd
-0.07
0.96%
7.19 29.04 28.74 2.68 5.94 2.85 17.82
BGA
Bega Cheese Ltd
-0.02
0.30%
6.74 35.61 22.94 0.52 1.93 0.60 11.82
CBO
Cobram Estate Olives Ltd
-0.06
2.26%
2.59 - - 4.79 2.48 6.63 185.44
RIC
Ridley Corporation Ltd
0.02
0.74%
2.74 38.29 13.42 0.35 2.01 0.53 4.50

Profile*

Nuchev Ltd

Nuchev Limited engages in the nutrition and wellness business across consumer, practitioner, distribution, and digital channels in Australia, China, Vietnam, and New Zealand. It offers goat-milk food and beverages; natural liquid vitamins; skincare products; and functional nutrition for weight wellness and vitality under the Oli6, Brauer, Skin Physics, and Rapid Loss brands. The company also provides clinically validated formulations, practitioner education, and professional support; bioavailable, well-tolerated formulations for energy, muscle, and nervous system support; alkaline mineral formulations; homeopathic solutions; liquid formulations; and herbal remedies under the Bio-Practica, Magnesium Diasporal, Basica, Heel, Brauer Professional, and Medicine Tree brands. In addition, it offers children's snacking products, goat functional food products, and full cream goat milk powder formats. The company sells its products through pharmacy, grocery, retail, and e-commerce channels; and digital platforms, as well as healthcare practitioners, clinics, health food stores, and other specialist channels. Nuchev Limited was incorporated in 2013 and is headquartered in Melbourne, Australia.

5 Bowen Crescent, Melbourne, VIC, Australia, 3000

61 3 4222 66570

Name Title Year Born
Mr. Ben Dingle Founder & Exec. Director NA
Mr. Michael Myers Chief Financial Officer NA
Mr. Gregory Norman Sean Kerr Chief Exec. Officer NA
Ms. Lisa Saunders Chief Marketing Officer NA
Ms. Tamara Barr Company Sec. NA
Mr. Michael Myers Interim CEO & CFO NA
Mr. Scott Koetsier Head of Sales & Business Development NA
Ms. Tamara Monica Barr Company Secretary NA
Mr. Michael Myers Interim CEO & CFO NA
Mr. Scott Koetsier Head of Sales & Business Development NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…